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Elevated levels of LDL cholesterol are a major risk fac-
tor for coronary artery stenosis;1 however, in many studies it 
was shown that patients with coronary artery stenosis have a 
normal range of LDL-cholesterol levels.2 LDL particles are 
known as heterogeneous particles due to their size, density, 
and lipid composition.3 Two evident phenotypes were rec-
ognized for LDL particles using gradient gel electrophoresis. 
Phenotype A consists of large, buoyant LDL particles with  
a size of more than 25.5 nm, and phenotype B is comprised 
of small dense LDL (sdLDL) and is 25.5 nm or less.4,5
Small dense LDLs are considered to be atherogenic 
because they readily penetrate the arterial wall and have a 
low affinity for LDL receptor. They are also susceptible to 
oxidation. In many studies, it was shown that coronary artery 
disease (CAD) risk was increased 2 to 3 fold in patients with 
sdLDL.6-8 Therefore, sdLDL is considered as a new marker 
for coronary artery stenosis.9
The standard method for separation of LDL particles is 
ultracentrifugation. Nuclear magnetic resonance (NMR) can 
also be used for determination of LDL diameter and concen-
tration.5 However, gradient gel electrophoresis is often used 
for LDL particle size measurement.10,11
The purpose of the present study is to investigate if the 
LDL particle size can be a better risk marker for coronary  
artery stenosis than other traditional markers.
Materials and Methods
This is a cross-sectional and case-control study. We stud-
ied an Iranian population that included 86 non-diabetic pa-
tients with coronary artery stenosis, 35 non-diabetic patients 
without coronary artery stenosis (who had the symptoms of 
stenosis) identified by angiography, and 30 healthy individu-
als without a history of diabetes and hypertension.
LDL particle size was measured using 2%–16% poly-
acrylamide gradient gel electrophoresis and Tris-base (90M), 
Boric acid (80M), and Na2EDTA (0.003M) buffer, PH 8.3. 
Serum samples were mixed in a 4:1 ratio with a solution con-
sisting of 40% sucrose and 0.05% bromophenol blue, and 
10 µL of samples were loaded to gels. Three standards were 
applied, such as thyroglobulin (sigma) and bovine albumin 
(Merck, Whitehouse Station, NJ) (2 mg/mL) with diameters 
of 17 nm and 7.1 nm, and serum VLDL with an approximate 
diameter of 34 nm.12 Five µL of thyroglobulin was also added 
to each serum sample as an internal standard. Gels were pre-
run for 15 minutes at 125 V. After loading samples, gels were 
run for 15 minutes at 75 V, 1 hour at 200 V, and eventually 
30 minutes at 400 V in 10°C-15°C. After electrophoresis, gels 
were stained with Coomassie Brilliant Blue (CBB) R-250. 
Coomassie Brilliant Blue stains protein standards, serum pro-
teins, and protein portion (apolipoprotein) of lipoproteins.  
To distinguish LDL, similar samples were mixed with Sudan 
Black (100 mg Sudan Black in 20 mL ethylene glycol) before 
electrophoresis or were stained with Sudan Red (20 mg Sudan 
Red in 20 mL methanol and 4 mL 0.1M NaOH) after elec-
trophoresis, by the remaining gel in Sudan Red for 24 hours. 
Comparison of these gels revealed the LDL band. LDL par-
ticle sizes were determined by using a calibration curve on the 
basis of their migration on the gel. The calibration curve was 
plotted by knowing 3 standards of migration distances on the 
gel and their size.
HDL and LDL cholesterol were measured by a homog-
enous method (respectively, [LDL, VLDL, and Chylomicrons 
were eliminated by reagent 1 (anti-human Beta Lipoprotein 
antibodies) then reagent 2 was added and HDL-C was de-
termined by CHOD-PAP method] and [HDL, VLDL, and 
Chylomicrons were eliminated by reagent 1 (Cholesterol ester 
hydrolase, Cholesterol oxidase, and Catalase) and the LDL 
was protected. Subsequently, reagent 2 was added, and LDL 
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Abstract 
Many studies have recently shown that 
coronary artery disease (CAD) risk was 
increased 2 to 3 fold in patients with small 
dense LDL (sdLDL). Therefore, the aim of this 
study was the evaluation of LDL particle size 
in patients with coronary artery stenosis and 
healthy individuals. This is a cross-sectional 
and case-control study. Eighty-six patients 
with coronary artery stenosis, 35 patients 
without coronary artery stenosis identified by 
angiography, and 30 healthy individuals were 
studied. LDL particle sizes were measured 
using 2%–16% polyacrylamide gradient gel 
electrophoresis. All values are expressed as 
the mean ±SD. One-way analysis of variance 
(ANOVA) was used to compare mean values 
among groups. In this study, mean LDL particle 
size was significantly smaller in patients with 
coronary artery stenosis (25.29 nm ± 0.38 nm) 
than patients without coronary artery stenosis 
(25.63 nm ± 0.2 nm) and healthy individuals 
(25.95 nm ± 0.4 nm) (P<0.001). The results of 
this study have shown that sdLDL can increase 
the risk of coronary artery stenosis.
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was determined by CHOD-PAP 
method])  (Pars Azmoon, Tehran, 
Iran). The levels of plasma cholesterol 
and triglyceride were determined 
using colorimetric enzymatic method 
(respectively, [Cholesterol oxidase 
+ 4-aminoantipyrine + phenol] and 
[glycerol phosphate kinase + amino-
antipyrine + 4chlorophenpl]) (Pars 
Azmoon). All values were measured 
using UV/Visible Spectrophotometer 
(Pharmacia, Biotech, Ultraspec 3000, 
Sparta, NJ).
All values are expressed as the 
mean ±SD. One-way  
analysis of variance (ANOVA) were used to compare mean 
values among groups. A statistically significant difference  
was defined as P<0.05.
Results
In this study, the serum triglyceride level was higher, but 
the serum HDL cholesterol was lower in patients with coro-
nary artery stenosis than other groups. However, the serum 
LDL cholesterol level had no significant difference among 
groups (Table 1).
As shown in Image 1, smaller LDL particles had more 
electrophoretic movement in the gradient gel because of their 
smaller size.
The diameter of LDL particles was measured by calibra-
tion curve on the basis of their electrophoretic movement 
(Figure 1).
In this study, mean LDL particle size was significantly 
smaller in patients with coronary artery stenosis (25.29 nm 
± 0.38 nm) than patients without coronary artery stenosis 
(25.63 nm ± 0.2 nm) and healthy individuals (25.95 nm ± 
0.4 nm) (P<0.001).
Discussion
The results of the current study confirm that LDL par-
ticle size should be considered as an important risk factor for 
coronary artery stenosis. The theory of sdLDL and CAD was 
studied in many retrospective4,13 and prospective14,15 studies. 
In addition, Shoji and colleagues have indicated that sdLDL 
can be the best marker of carotid atherosclerosis.16
Increased levels of LDL cholesterol are a major risk fac-
tor for CAD,1 however, in many studies it was shown that 
patients with CAD have a normal range of LDL cholesterol 
levels.2 In our study, patients with coronary artery stenosis 
had a normal range of LDL cholesterol levels, too. Griffen 
and colleagues reported that the elevated level of LDL up to a 
triglyceride value of 1.5 mmol/l was because of an increase in 
the buoyant subclass. About 1.5 mmol/l sdLDL was shown to 
increase significantly, while the concentration of the large and 
buoyant LDL dropped, resulting in a decrease of total LDL.17 
Therefore, an elevated level of sdLDL can be an important 
risk factor for artery stenosis.
In the present study, patients with coronary artery steno-
sis the size of the LDL particles were smaller, so our results 
are in agreement with the study of Koba,7 Yoon,18 St-Pierre,19 
Liu,20 Kamigaki,21 Skoglund-Anderson,22 and Kwon.23 How-
ever, in the Hulthe24 study, large LDL was correlated with 
Table 1_Baseline Characteristics of the Subjects
Variables P  With Stenosis n=86 Without Stenosis n=35 Healthy n=30   
Sex (female, male)  (31/55) (21/14) (15/15)  
Age (y)  0.038 56.28 ± 9.4  54.66 ± 10.8  50.69 ± 10.2  
LDL-C (mg/dL)  0.583 119.47 ± 16.6 116.11 ± 17.0  118.83 ± 13.3  
HDL-C (mg/dL)  0.000 37.05 ± 6.4  43.17 ± 6.8  47.57 ± 10.4  
Triglyceride (mg/dL)  0.002 177.70 ± 62.6  141.21 ± 39.4 153.3 ± 28.4 
Total cholesterol (mg/dL)  0.522 177.52 ± 44.4 168.91 ± 35.7 178.13 ± 28.6 
 Values are mean ±SD
Image 1_Gel stained by CBB. Arrows show the lanes with smaller LDL  
particle size. 
Figure 1_Calibration curve plotted using 3 standards with known 
diameters, such as thyroglobulin (17 nm), bovin albumun (7.1 nm), 
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CAD, and in the Gray study there was no difference in LDL 
particle size between CAD patients and healthy individuals. 
Large LDL is common among the Native American society 
where the CAD prevalence is high.24 Large LDL is current 
in countries with high prevalence of CAD such as Scotland, 
Korea, and the United States;5 therefore, ethnic and genetic 
agents may have an important role. Many studies have re-
vealed that sdLDL particles can intensify the atherosclerotic 
process due to their penetration of the arterial wall, less affin-
ity for LDL receptor, and susceptibility to oxidation.26
Our previous study showed that patients with coronary ar-
tery stenosis have higher levels of sdLDL than patients without 
coronary artery stenosis and healthy individuals.27 According 
to our previous study, LDL particle size is negatively correlated 
with sdLDL levels. Therefore, patients with higher levels of 
sdLDL have a smaller LDL size. Hirano and colleagues have 
shown that sdLDL levels correlated with LDL size.10
Our results indicated that patients with coronary artery 
stenosis have elevated serum triglyceride levels and reduced 
HDL cholesterol levels. Serum triglyceride is a primary factor 
in sdLDL production. In this study, patients with coronary 
artery stenosis had higher levels of serum triglyceride. Increased 
levels of serum triglyceride leads to VLDL1 accumulation, due 
to increased production and reduced clearance of VLDL1. 
VLDL1 lypolisis produces LDL particles which are unable 
to attach to LDL receptors due to Apo B100 conformational 
changes so its retention time is longer than LDLs, which are 
produced by VLDL2.28 This form of LDL has sufficient time 
to be altered by CETP. Therefore, in a VLDL1 level elevation, 
LDL will lose cholesteryl ester and obtain triglyceride through 
CETP mechanism. Triglyceride-rich LDL is a good substrate 
for hepatic lipase. Hepatic lipase withdraws enough amounts 
of core lipid (triglyceride) and the superficial lipid, and can 
shift LDL particles toward sdLDL particles.26 Hence, it is con-
siderable that increased serum triglyceride can lead to sdLDL 
production in patients with coronary artery stenosis.
In conclusion, we demonstrate that patients with coro-
nary artery stenosis have smaller LDL particles, so sdLDL  
can increase the risk of coronary artery stenosis.  LM
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